Back to NewEdge Wealth, LLC NewEdge Wealth, LLC

PYXSPYXS
7 quarters

Position history for NewEdge Wealth, LLCNewEdge Wealth, LLC's holdings in PYXIS ONCOLOGY INC

NewEdge Wealth, LLC holds 116,006 shares of PYXS (PYXIS ONCOLOGY INC), worth $169,369 as of 2026-Q1. PYXS represents 0.0% of NewEdge Wealth, LLC's portfolio.

Current Value

$169,369

Current Shares

116,006

Total Value Change

-$256,373

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
116,006
0.0%
$169,3690.0%$1.43
0
2025-Q4
Unchanged
116,006
0.0%
$133,4070.0%$1.09
0
2025-Q3
Unchanged
116,006
0.0%
$453,5830.0%$2.20
0
2025-Q2
Unchanged
116,006
0.0%
$124,1260.0%$1.10
0
2025-Q1
Decreased
116,006
0.0%
$113,6740.0%$1.06
0
2024-Q4
Increased
116,009
0.0%
$180,9740.0%$1.56
23
2024-Q3
New
116,006
-
$425,7420.0%$3.62
33

Other major holders of PYXS: RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP, CITADEL ADVISORS LLC, Janus Henderson Group Ltd., BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used